PolyPeptide Group AG
SIX:PPGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PolyPeptide Group AG
SIX:PPGN
|
CH |
|
T
|
TUI AG
XMUN:TUI1
|
DE |
|
United Utilities Group PLC
LSE:UU
|
UK |
|
Unicharm Corp
F:UN41
|
JP |
|
J
|
JCDecaux SE
XMUN:DCS
|
FR |
|
A
|
Adecoagro SA
F:ACD
|
LU |
|
L
|
London Stock Exchange Group PLC
OTC:LNSTY
|
UK |
|
L
|
London Stock Exchange Group PLC
F:LS4C
|
UK |
|
V
|
Vinci SA
XETRA:SQU
|
FR |
|
D
|
Deutsche Telekom AG
F:DTEA
|
DE |
|
A
|
Abliva AB
F:NTP
|
SE |
|
S
|
Sany Heavy Equipment International Holdings Company Ltd
F:YXS
|
CN |
Wall St Price Targets
PPGN Price Targets Summary
PolyPeptide Group AG
According to Wall Street analysts, the average 1-year price target for PPGN is 41.96 CHF with a low forecast of 38.38 CHF and a high forecast of 47.25 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PPGN's stock price target?
Price Target
41.96
CHF
According to Wall Street analysts, the average 1-year price target for PPGN is 41.96 CHF with a low forecast of 38.38 CHF and a high forecast of 47.25 CHF.
What is the Revenue forecast for PolyPeptide Group AG?
Projected CAGR
17%
Over the last 6 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 5 years is 17%.
What is the Gross Profit forecast for PolyPeptide Group AG?
Projected CAGR
36%
Over the last 6 years, the compound annual growth rate for Gross Profit has been -1%. The projected CAGR for the next 4 years is 36%.
What is the Operating Income forecast for PolyPeptide Group AG?
Projected CAGR
43%
Over the last 6 years, the compound annual growth rate for Operating Income has been -18%. The projected CAGR for the next 8 years is 43%.
